Navigation Links
Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
Date:12/3/2008

NEW YORK, Dec. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the company will provide an update on milestones achieved in 2008 and preview objectives for 2009 during its annual Investor and Analyst Briefing to be held in New York City today.

David Smoller, Ph.D., President of Sigma-Aldrich Corporation's Research Biotech Business Unit will discuss the progress and expected potential of the two companies' collaboration to commercialize zinc finger DNA-binding protein (ZFP) technology for research applications. Dr. Smoller will be joined by Edward Lanphier, Sangamo's president and CEO and other members of Sangamo's senior management team.

"Sigma is committed to providing breakthrough products to its customers in laboratories worldwide and we expect Sangamo's ZFP technology to be nothing short of revolutionary for research applications," commented Dr. Smoller. "Marketed under the trademark CompoZr, the zinc finger nuclease (ZFN) technology makes available, for the first time, simple, efficient genomic editing. CompoZr(TM) ZFN reagents can be used to efficiently create modified cell lines and model organisms with precise and heritable gene deletions, insertions or modifications using simple, widely used laboratory procedures. This is proven technology with strong potential."

"The past year has been a year of real progress for our ZFP technology platform," said Edward Lanphier, president and CEO of Sangamo. "We are successfully translating the broad applicability of our technology into opportunities for both novel human therapeutics and non-therapeutic industrial applications. Our unique hybrid business model maximizes the value of our ZFP technology platform and has enabled us to make significant progress in moving our lead ZFP Therapeutic into multiple Phase 2 clinical trials
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
2. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
3. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
7. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
8. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
11. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... York , July 11, 2014 ... Transparency Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative ... Share, Growth, Trends and Forecast, 2013-2019" the global endoscopy ... 2012 and is expected to grow at a CAGR ... estimated value of USD 36.9 billion in 2019. ...
(Date:7/11/2014)... 2014 Show organisers ... Health Expo 2014 were a brand new ... London , plus a 10% ...        (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) ...      (Photo: http://photos.prnewswire.com/prnh/20140711/696892-b ...
(Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
... Kendle (Nasdaq: KNDL ), a leading, global full-service clinical research organization, today ... on June 23, 2010 , at the InterContinental Hotel in Boston . ... Kendle,s formal presentation will be given by Chairman ... Time . , , , ...
... June 17 Brainlab AG today announced that it ... business unit of the Toshiba Group, to integrate its Aquilion™ LB ... operating room (OR). , , ... Stephan Holl , Chief Operating Officer, Brainlab, indicated that ...
Cached Medicine Technology:Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference 2Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite 2Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite 3
(Date:7/11/2014)... New research from UC San Francisco shows that ... Medea Project helps women living with HIV disclose ... self-efficacy and the safety and quality of their ... study,s first author, Edward L. Machtinger, MD, director ... 90 percent of our patients are on effective ...
(Date:7/11/2014)... Emily Johnson, owner of the Portland Fit Body Boot ... camp has held two charity workout events and is about ... from 7:15 - 8:30 at Col Summers City Park, SE 20th ... session raised $510 for Medical Teams International. Their second workout event ... Dream. On July 26th, Johnson and Portland Fit Body Boot ...
(Date:7/11/2014)... As reported by Forbes in the article ... To Blame (6/30), Indino Downey has reportedly been arrested ... smoke it with. His father, well-known actor Robert Downey ... from him may have something to do with his ... the 1980s and 1990s for substance abuse before finally ...
(Date:7/11/2014)... Los Angeles dental implant ... mini and full mouth implants to replace missing teeth. ... distinguishes dental implants from other tooth replacements: They replace ... This alone prevents the long-term complications of missing teeth, ... to comfort, appearance and systemic health. Mini implants broaden ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- Polio is history ... places like Afghanistan, Nigeria and Pakistan. Giving vaccinated children ... their immunity and help eradicate the highly infectious disease, ... is highly effective, immunity wanes as early as a ... be infected and contribute to the spread of the ...
Breaking Medicine News(10 mins):Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 3Health News:Roberty Downey's Son Arrested For Cocaine 2Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Researchers Assess New Way to Boost Polio Immunity 2
... LOS ANGELES , March ... pain interferes with daily life as well as with a person,s ... and grandchildren, spinal health is a critical key to remaining mobile. ... with little or no result, Orthopedic Spine Surgery is ...
... March 12 Each year, nearly three million youths run away from home, putting themselves at a high ... In" campaign to raise awareness of the risks associated with teen homelessness and the services available to youth in crisis. ... ... , , ...
... common for patients 65 and older to receive potentially inappropriate medications when treated in an emergency room. , ... , , ... ... ...
... ... the expiration of its rights offering to 5:00 p.m., New York City time, on Friday, ... ... Bulletin Board: HBDT), a leading technology innovator in the marketing, sales and administration of a ...
... lack of insurance contribute to the problem , FRIDAY, March ... severe chronic kidney disease are far more likely to progress ... new U.S. study has found. , The finding came from ... chronic kidney disease, stages three to five, and were receiving ...
... of Smaller Enterprises (COSE): , ... , , ... ... As Congress and President Obama continue to discuss opportunities to overhaul health care, ...
Cached Medicine News:Health News:World Renowned Los Angeles Surgeon Pioneers Alternative Orthopedic Spine Surgery 2Health News:National Safe Place Week Helps Prevent Teen Homelessness 2Health News:National Safe Place Week Helps Prevent Teen Homelessness 3Health News:National Safe Place Week Helps Prevent Teen Homelessness 4Health News:Some Older ER Patients Are Getting the Wrong Medicines, U-M Study Finds 2Health News:Some Older ER Patients Are Getting the Wrong Medicines, U-M Study Finds 3Health News:Some Older ER Patients Are Getting the Wrong Medicines, U-M Study Finds 4Health News:Some Older ER Patients Are Getting the Wrong Medicines, U-M Study Finds 5Health News:Health Benefits Direct Announces Extension of Expiration of Rights Offering to March 26, 2010 2Health News:Health Benefits Direct Announces Extension of Expiration of Rights Offering to March 26, 2010 3Health News:U.S. Minorities Especially Vulnerable to Kidney Failure 2Health News:What Real Health Care Reform Must Address 2Health News:What Real Health Care Reform Must Address 3Health News:What Real Health Care Reform Must Address 4Health News:What Real Health Care Reform Must Address 5
... The NMP22® Test Kit is a quantitative ... NMP22 protein. Healthy individuals generally have very small ... the level of NMP22 protein is often elevated ... even at early stages of the disease. The ...
... connect an infusion bag ... and then to a ... to conduct urodynamics studies. ... Medical Technologies infusion pumps. ...
Used for cystometry and urethral pressure profilometry. A loop is employed to enhance catheter retention and stabilization within the bladder. Supplied sterile in peel-open packages. Intended for one...
... Used for cystometry and urethral pressure ... for faster filling of the bladder ... Dual lumen catheter construction allows the ... is performed. Triple lumen catheter construction ...
Medicine Products: